Douglas Pharmaceuticals America

Douglas Pharmaceuticals is a New Zealand-based pharmaceutical company with a significant global presence, including its United States subsidiary, Douglas Pharmaceuticals America. The company specializes in the development, manufacturing, and distribution of high-quality generic and repurposed pharmaceutical products, with a particular focus on complex chemistry and niche therapeutic areas. Their business model encompasses both a robust portfolio of commercialized products in dermatology and oncology, as well as a contract development and manufacturing organization (CDMO) service for international partners. Douglas is actively engaged in clinical research to repurpose existing molecules for new indications, such as treatment-resistant depression and various cancers.